140 related articles for article (PubMed ID: 25217230)
1. Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.
Kreher S; Strehlow F; Martus P; Roth P; Hertenstein B; Röth A; Birnbaum T; Griesinger F; Rauch M; Kanz L; Thiel E; Weller M; Korfel A
Ann Hematol; 2015 Mar; 94(3):409-14. PubMed ID: 25217230
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
Korfel A; Thiel E; Martus P; Möhle R; Griesinger F; Rauch M; Röth A; Hertenstein B; Fischer T; Hundsberger T; Mergenthaler HG; Junghanß C; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Roth P; Bamberg M; Pietsch T; Weller M
Neurology; 2015 Mar; 84(12):1242-8. PubMed ID: 25716362
[TBL] [Abstract][Full Text] [Related]
4. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
[TBL] [Abstract][Full Text] [Related]
5. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
Roth P; Martus P; Kiewe P; Möhle R; Klasen H; Rauch M; Röth A; Kaun S; Thiel E; Korfel A; Weller M
Neurology; 2012 Aug; 79(9):890-6. PubMed ID: 22895585
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.
Zeremski V; Koehler M; Fischer T; Schalk E
Ann Hematol; 2016 Apr; 95(5):793-9. PubMed ID: 26801791
[TBL] [Abstract][Full Text] [Related]
7. Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.
Roth P; Keller A; Hoheisel JD; Codo P; Bauer AS; Backes C; Leidinger P; Meese E; Thiel E; Korfel A; Weller M
Eur J Cancer; 2015 Feb; 51(3):382-90. PubMed ID: 25534293
[TBL] [Abstract][Full Text] [Related]
8. [Our experience with the treatment of primary lymphomas of the central nervous system].
Motyčková M; Smolej L; Belada D; Malý J; Zák P
Vnitr Lek; 2012 Dec; 58(12):915-21. PubMed ID: 23427949
[TBL] [Abstract][Full Text] [Related]
9. The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma.
Madle M; Krämer I; Lehners N; Schwarzbich M; Wuchter P; Herfarth K; Egerer G; Ho AD; Witzens-Harig M
Ann Hematol; 2015 Nov; 94(11):1853-7. PubMed ID: 26268792
[TBL] [Abstract][Full Text] [Related]
10. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
O'Brien PC; Roos DE; Pratt G; Liew KH; Barton MB; Poulsen MG; Olver IN; Trotter GE;
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):408-13. PubMed ID: 16198065
[TBL] [Abstract][Full Text] [Related]
11. Results of treatment of 112 cases of primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
[TBL] [Abstract][Full Text] [Related]
12. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
13. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
Ferreri AJ; Blay JY; Reni M; Pasini F; Gubkin A; Tirelli U; Calderoni A; Zucca E; Cortelazzo S; Chassagne C; Tinguely M; Borisch B; Berger F; Ponzoni M; Cavalli F;
Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702
[TBL] [Abstract][Full Text] [Related]
14. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.
Shibamoto Y; Ogino H; Hasegawa M; Suzuki K; Nishio M; Fujii T; Kato E; Ishihara S; Sougawa M; Kenjo M; Kawamura T; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):809-13. PubMed ID: 15936564
[TBL] [Abstract][Full Text] [Related]
15. Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
Jahnke K; Korfel A; Komm J; Bechrakis NE; Stein H; Thiel E; Coupland SE
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):663-9. PubMed ID: 16228920
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.
Kreher S; Jöhrens K; Strehlow F; Martus P; Borowiec K; Radke J; Heppner F; Roth P; Thiel E; Pietsch T; Weller M; Korfel A
Neuro Oncol; 2015 Jul; 17(7):1016-21. PubMed ID: 25817328
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy for primary CNS lymphoma.
DeAngelis LM; Yahalom J; Thaler HT; Kher U
J Clin Oncol; 1992 Apr; 10(4):635-43. PubMed ID: 1548527
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
